New players in the landscape of renal cell carcinoma bone metastasis and therapeutic opportunities

Abstract

Approximately one‐third of advanced renal cell carcinoma (RCC) patients develop osteolytic bone metastases, leading to skeletal complications. In this review, we first provide a comprehensive perspective of seminal studies on bone metastasis of RCC describing the main molecular modulators and growth factor signaling pathways most important for the RCC‐stimulated osteoclast‐mediated bone destruction. We next focus on newer developments revealing with in‐depth details, the bidirectional interplay between renal cancer cells and the immune and stromal microenvironment that can through epigenetic reprogramming, profoundly affect the behaviors of transformed cells. Understanding their mechanistic interactions is of paramount importance for advancing both fundamental and translational research. These new investigations into the landscape of RCC‐bone metastasis offer novel insights and identify potential avenues for future therapeutic interventions.